Differences in Postprandial Glucose Changes
Diabetes Mellitus, Type II, Overweight or Obesity
About this trial
This is an interventional other trial for Diabetes Mellitus, Type II
Eligibility Criteria
Inclusion Criteria: A diagnosis of T2DM for any length of time, last HbA1C (within the last 6 months) of < / = 8% Exclusion Criteria: 1. On insulin for any length of time
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Shake 1 then Shake 2
Shake 2 then Shake 1
Participants will consume 1 bottle of shake 1 and take their normal morning medications. After this 3ml blood samples will be taken via the cannula at 30mins, 60mins and 120 mins post meal. During the waiting period between phlebotomy, a sensory analysis questionnaire which asks participants to rate the taste, appearance, texture and smell of the product. After a 1-week washout period, the entire protocol will be repeated using Shake 2.
Participants will consume 1 bottle of Shake 2 and take their normal morning medications. After this 3ml blood samples will be taken via the cannula at 30mins, 60mins and 120 mins post meal. During the waiting period between phlebotomy, a sensory analysis questionnaire which asks participants to rate the taste, appearance, texture and smell of the product. After a 1-week washout period, the entire protocol will be repeated using Shake 1.